#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hyperphagia Adrenogenital syndrome Chronic myelomonocytic leukaemia Albright's disease Hyperinsulinism Spinal cord injury Cholangitis sclerosing Glomerulonephritis membranous Angiosarcoma metastatic Cutaneous T-cell lymphoma stage I Pyoderma gangrenosum Myelin oligodendrocyte glycoprotein antibody-associated disease Central nervous system lymphoma Metabolic disorder Retinal artery occlusion More trials…

    Learn about Rare Diseases

    Pleural mesothelioma malignant – Trials in Disease Haemophilia – Life with Disease Progressive supranuclear palsy – Treatment Epidermolysis bullosa Hereditary neuropathic amyloidosis Nephroblastoma – Trials in Disease Pulmonary sarcoidosis – Diagnostics Burkitt’s lymphoma – Treatment Niemann-Pick disease – Treatment Rhabdomyosarcoma recurrent More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cariprazine Hydrochloride ACARBOSE Anhydrous Cyclophosphamide ACICLOVIR SODIUM Doxycycline Hyclate GSKVX000000030918 Rct2100 Sodium Iodide (123 I) Oxytocin Synthetic Trientine Dihydrochloride Gsk4004280 Trabectedin Desonide Ropivacaine Hydrochloride [99MTC]PSMA I&S Lasn01 HTL0022537 Giroctocogene Fitelparvovec PRILOCAINE HYDROCHLORIDE Fludarabine Phosphate Ph. Eur. More therapies…

    Learn about Your Condition

    Breast cancer Ventricular extrasystoles Small intestine leiomyosarcoma Malformation venous Fibromyalgia Anal incontinence Diabetic foot Pancreatic neoplasm BRAF gene mutation Skin papilloma Rectal cancer recurrent Haemorrhage Childhood asthma Suicidal ideation Oedema peripheral More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Methoxyflurane for Pain Relief in Patients with Heart Attack

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myocardial infarction
    Investigated Drugs:
    • MORPHINE
    France

  • Study on the Effectiveness and Safety of Masitinib and Riluzole for Patients with Amyotrophic Lateral Sclerosis (ALS)

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Riluzole
    • Masitinib
    France Germany Greece Latvia Slovenia Spain +1

  • Study on Intraperitoneal Treatment with Fosfomycin, Metronidazole, and Molgramostim for Patients with Multi-Quadrant Peritonitis Undergoing Abdominal Surgery

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Peritonitis
    Investigated Drugs:
    • Fosfomycin
    • Molgramostim
    • Metronidazole
    Denmark

  • Study on the Safety and Immune Response of OVX033 Vaccine for Adults with Sarbecovirus Disease

    Not yet recruiting

    1 1 1
    Investigated Drugs:
    • Sodium Chloride
    France

  • Study on Zolpidem’s Effects in Patients with Vision Impairments, Disorders of Consciousness, and Neurotypical Volunteers

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • ZOLPIDEM TARTRATE
    • Mannitol
    Belgium

  • Study on Early Measles Immunization with MMR-0 Vaccine for Infants Under 12 Months During a Measles Outbreak

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Measles Virus Edmonston-Enders Strain (Live, Attenuated) Produced In Chick Embryo Cells
    • Mumps Virus Jeryl Lynn (Level B) Strain (Live, Attenuated) Produced In Chick Embryo Cells
    • Rubella Virus Wistar Ra 27/3 Strain (Live, Attenuated) Produced In Wi-38 Human Diploid Lung Fibroblasts
    The Netherlands
Previous Page
1 … 785 786 787 788 789 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!